Literature DB >> 3553225

Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies.

J R Carlson, J Yee, S H Hinrichs, M L Bryant, M B Gardner, N C Pedersen.   

Abstract

There was 100% agreement between the results of indirect immunofluorescence (IF) and Western blot testing when these methods were used to detect antibodies to the human immunodeficiency virus in sera from 25 patients with acquired immune deficiency syndrome (AIDS), 20 patients with AIDS-related complex, 186 subjects at high risk for AIDS, and 40 healthy heterosexuals. However, there was only an 88.7% correlation between IF and Western blot results for 728 sera from blood and plasma donor centers that were selected on the basis of screening enzyme immunoassay reactivity. IF tests yielded nine false-negatives and were equivocal, yielding a nonspecific pattern of reactivity for both infected and uninfected cells for 73 of these specimens. The IF and Western blot methods were equal in performance for the detection of anti-human immunodeficiency virus antibodies in the high-risk and unselected low-risk groups, proving to be a practical approach for testing specimens from these subjects. However, the Western blot was the most acceptable method for the validation of specimens from groups at low risk for AIDS that were selected based on enzyme immunoassay reactivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553225      PMCID: PMC265963          DOI: 10.1128/jcm.25.3.494-497.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Authors:  R S Blumberg; E G Sandstrom; T J Paradis; D N Neumeyer; M G Sarngadharan; K L Hartshorn; R E Byington; M S Hirsch; R T Schooley
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

2.  Prevalence of HTLV-III antibody in American blood donors.

Authors:  J B Schorr; A Berkowitz; P D Cumming; A J Katz; S G Sandler
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

3.  Asymptomatic blood donor with a false positive HTLV-III Western blot.

Authors:  M S Saag; J Britz
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

4.  HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

Authors:  P Kühnl; S Seidl; G Holzberger
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

5.  AIDS serology testing in low- and high-risk groups.

Authors:  J R Carlson; M L Bryant; S H Hinrichs; J K Yamamoto; N B Levy; J Yee; J Higgins; A M Levine; P Holland; M B Gardner
Journal:  JAMA       Date:  1985-06-21       Impact factor: 56.272

6.  Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods.

Authors:  D Gallo; J L Diggs; G R Shell; P J Dailey; M N Hoffman; J L Riggs
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

7.  Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.

Authors:  J I Esteban; J W Shih; C C Tai; A J Bodner; J W Kay; H J Alter
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

8.  High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.

Authors:  L S Kaminsky; T McHugh; D Stites; P Volberding; G Henle; W Henle; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells.

Authors:  E G Sandstrom; R T Schooley; D D Ho; R Byington; M G Sarngadharan; M E MacLane; M Essex; R C Gallo; M S Hirsch
Journal:  Transfusion       Date:  1985 Jul-Aug       Impact factor: 3.157

  9 in total
  12 in total

1.  Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing.

Authors:  R N Taylor; T L Hearn; W O Schalla; R O Valdiserri
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

2.  Humoral immune response to the bovine immunodeficiency-like virus in experimentally and naturally infected cattle.

Authors:  C A Whetstone; M J VanDerMaaten; J W Black
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.

Authors:  V L Ng; C S Chiang; C Debouck; M S McGrath; T H Grove; J Mills
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

4.  Performance and reliability of five commercial enzyme-linked immunosorbent assay kits in screening for anti-human immunodeficiency virus antibody in high-risk subjects.

Authors:  G Ozanne; M Fauvel
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

5.  Isolation of a highly cytopathic lentivirus from a nondomestic cat.

Authors:  M C Barr; L Zou; D L Holzschu; L Phillips; F W Scott; J W Casey; R J Avery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 6.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

7.  Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation.

Authors:  M Fauvel; G Ozanne
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

8.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Comparison of five commercial western blot kits for detection of human immunodeficiency virus 1.

Authors:  D Pohlod; L Saravolatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

10.  Seroepidemiology of viral infections among intravenous drug users in northern California.

Authors:  J B Zeldis; S Jain; I K Kuramoto; C Richards; K Sazama; S Samuels; P V Holland; N Flynn
Journal:  West J Med       Date:  1992-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.